港股生物医药概念走强，荣昌生物涨超14%

Group 1 - The Hong Kong stock market's biopharmaceutical sector has shown strong performance, with Rongchang Biologics rising over 14% [1] - Other companies in the sector, including Tigermed, Innovent Biologics, and WuXi Biologics, also experienced gains [1]